Refine
Has Fulltext
- yes (17)
Is part of the Bibliography
- yes (17)
Year of publication
Document Type
- Journal article (16)
- Preprint (1)
Language
- English (17) (remove)
Keywords
- HUWE1 (3)
- MIZ1 (3)
- MYC (3)
- cancer (2)
- colorectal cancer (2)
- differentiation (2)
- metastasis (2)
- transcription factor MIZ-1 (2)
- 28 (1)
- AMP-activated protein kinase (AMPK) (1)
- ARF tumor-suppressor induced lymphomagenes (1)
- BCL-X-L P53 (1)
- Beige adipocytes (1)
- Biologie (1)
- C-MYC (1)
- C-MYC PUMA (1)
- C/EBP (1)
- CRC (1)
- CX5461 (1)
- ChIP-sequencing (1)
- Enzyme Regulation (1)
- Fbw7 (1)
- HECT (1)
- HECT Ligase (1)
- JNK (1)
- MAPK signaling cascades (1)
- MYCNv (1)
- Medicine (1)
- Melanoma (1)
- Molecular Biophysics (1)
- NOTCH (1)
- P14ARF (1)
- P15(INK4B) (1)
- P21 (1)
- POZ domain (1)
- Protein kinase D1 (PKD1) (1)
- RNAPOL1 (1)
- Structural Biology (1)
- Ubiquitin (1)
- WDR5 (1)
- X-Ray Chrystallography (1)
- achaete-scute homolog 1 (1)
- breast-cancer cells (1)
- c-myc (1)
- caco-2 cells (1)
- cancer biology (1)
- cancer cells (1)
- carcinomas (1)
- cell biology (1)
- cell-cycle arrest (1)
- cell-cycle arrest cancer therapy (1)
- colon (1)
- c‐Myc (1)
- dMyc (1)
- digestive system (1)
- dmP53 (1)
- drug discovery (1)
- endoreplication (1)
- epithelial cells (1)
- gene expression (1)
- growth (1)
- human (1)
- in-vivo expression (1)
- lung cancer (1)
- mathematical modeling (1)
- mouse (1)
- neuroblastoma cell (1)
- neurogenic locus notch homolog (1)
- oncogenic transformation (1)
- pharmacology (1)
- prolactin (1)
- proliferation (1)
- promoter affinity (1)
- proteasome system (1)
- protein biosynthesis & quality control (1)
- protein expression (1)
- retinoblastoma protein (1)
- ribosome (1)
- salivary gland (1)
- senescence (1)
- small cell lung cancer (1)
- small interferring RNA (1)
- squamous cell carcinoma (1)
- transcription (1)
- transcriptional responses (1)
- transformation (1)
- transgenic mice (1)
- translational regulation (1)
- tumor suppressor (1)
- ubiquitin (1)
- ubiquitination (1)
- β3 adrenergic receptor (ADRB3) (1)
- ∆Np63 (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (17)
- Rudolf-Virchow-Zentrum (4)
- Comprehensive Cancer Center Mainfranken (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Klinik und Poliklinik für Strahlentherapie (2)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Medizinische Klinik und Poliklinik II (1)
- Pathologisches Institut (1)
Formation of the Aurora-A–MYCN complex increases levels of the oncogenic transcription factor MYCN in neuroblastoma cells by abrogating its degradation through the ubiquitin proteasome system. While some small-molecule inhibitors of Aurora-A were shown to destabilize MYCN, clinical trials have not been satisfactory to date. MYCN itself is considered to be `undruggable' due to its large intrinsically disordered regions. Targeting the Aurora-A–MYCN complex rather than Aurora-A or MYCN alone will open new possibilities for drug development and screening campaigns. To overcome the challenges that a ternary system composed of Aurora-A, MYCN and a small molecule entails, a covalently cross-linked construct of the Aurora-A–MYCN complex was designed, expressed and characterized, thus enabling screening and design campaigns to identify selective binders.